Cargando…

Acute death caused by invasive aspergillosis after living-donor liver transplantation despite good graft function: a case report

BACKGROUND: Invasive aspergillosis (IA) is one of the most serious causes of death after liver transplantation (LT). IA is the second most common fungal infection, and its mortality rate exceeds 80%. CASE PRESENTATION: A 67-year-old man presented to our hospital because of fulminant hepatitis caused...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tomiyama, Takahiro, Motomura, Takashi, Iseda, Norifumi, Morinaga, Akinari, Shimagaki, Tomonari, Kurihara, Takeshi, Wang, Huanlin, Toshima, Takeo, Nagao, Yoshihiro, Itoh, Shinji, Harada, Noboru, Yoshizumi, Tomoharu, Mori, Masaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116460/ https://www.ncbi.nlm.nih.gov/pubmed/33978845 http://dx.doi.org/10.1186/s40792-021-01203-w

Ejemplares similares

Impact and risk factors for skeletal muscle mass loss after hepatic resection in patients with hepatocellular carcinoma
por: Itoh, Shinji, et al.
Publicado: (2021)

Ferroptosis is induced by lenvatinib through fibroblast growth factor receptor‐4 inhibition in hepatocellular carcinoma
por: Iseda, Norifumi, et al.
Publicado: (2022)

Caution for living donor liver transplantation with congenital portosystemic shunt: a case report
por: Nagao, Yoshihiro, et al.
Publicado: (2022)

Which is better to use “body weight” or “standard liver weight”, for predicting small‐for‐size graft syndrome after living donor liver transplantation?
por: Toshima, Takeo, et al.
Publicado: (2020)

Impact of Nuclear Factor Erythroid 2–Related Factor 2 in Hepatocellular Carcinoma: Cancer Metabolism and Immune Status
por: Iseda, Norifumi, et al.
Publicado: (2021)

Hemophagocytic syndrome after living donor liver transplantation: a case report with a review of the literature
por: Iseda, Norifumi, et al.
Publicado: (2018)

CMTM6 Stabilizes PD‐L1 Expression and Is a New Prognostic Impact Factor in Hepatocellular Carcinoma
por: Yugawa, Kyohei, et al.
Publicado: (2020)

Clinical effects of the use of the indocyanine green fluorescence imaging technique in laparoscopic partial liver resection
por: Itoh, Shinji, et al.
Publicado: (2022)

Prevention of bile duct injury using indocyanine green fluorescence in laparoscopic liver cyst fenestration for giant liver cyst: a case report
por: Shimagaki, Tomonari, et al.
Publicado: (2022)

ARID1A Deficiency Is Associated With High Programmed Death Ligand 1 Expression in Hepatocellular Carcinoma
por: Iseda, Norifumi, et al.
Publicado: (2020)

Impact of Metabolic Activity in Hepatocellular Carcinoma: Association With Immune Status and Vascular Formation
por: Itoh, Shinji, et al.
Publicado: (2021)

Liver resection with right hepatic vein reconstruction using the internal jugular vein: a case report
por: Shimagaki, Tomonari, et al.
Publicado: (2016)

Donor Skeletal Muscle Quality Affects Graft Mortality After Living Donor Liver Transplantation- A Single Center, Retrospective Study
por: Tomiyama, Takahiro, et al.
Publicado: (2022)

Modulation of Nqo1 activity intercepts anoikis resistance and reduces metastatic potential of hepatocellular carcinoma
por: Shimokawa, Masahiro, et al.
Publicado: (2020)

Myeloid-derived suppressor cell infiltration is associated with a poor prognosis in patients with hepatocellular carcinoma
por: Tomiyama, Takahiro, et al.
Publicado: (2022)

Comparison of the prognostic effect of sarcopenia on atezolizumab plus bevacizumab and lenvatinib therapy in hepatocellular carcinoma patients
por: Toshida, Katsuya, et al.
Publicado: (2022)

Obesity is a risk factor for intrahepatic cholangiocarcinoma progression associated with alterations of metabolic activity and immune status
por: Yugawa, Kyohei, et al.
Publicado: (2021)

Cancer‐associated fibroblasts promote tumor cell growth via miR‐493‐5p in intrahepatic cholangiocarcinoma
por: Toshida, Katsuya, et al.
Publicado: (2022)

The authors’ reply: Indispensable discrepancy between predicted graft “volume” and actual graft “weight” in clinical practice in living‐donor liver transplantation
por: Toshima, Takeo, et al.
Publicado: (2021)

Liver transplantation for cryptogenic liver failure caused by diffuse hepatic angiosarcoma: case report
por: Yoshida, Yoshihiro, et al.
Publicado: (2017)

Up‐regulated LRRN2 expression as a marker for graft quality in living donor liver transplantation
por: Tomiyama, Takahiro, et al.
Publicado: (2022)

Multiple liver metastases originating from synchronous double cancer of neuroendocrine tumor and rectal cancer: a case report
por: Omori, Sachie, et al.
Publicado: (2020)

Retroperitoneal schwannoma preoperatively diagnosed as liver metastasis from colon cancer: A case report
por: Wang, Huanlin, et al.
Publicado: (2019)

Multiple hepatic sclerosing hemangiomas: a case report and review of the literature
por: Yugawa, Kyohei, et al.
Publicado: (2018)

Living donor liver transplantation indicated for compensated liver cirrhosis with symptomatic gallstone diseases: report of two cases
por: Bekki, Yuki, et al.
Publicado: (2016)

Suppression of optineurin impairs the progression of hepatocellular carcinoma through regulating mitophagy
por: Inokuchi, Shoichi, et al.
Publicado: (2021)

Predictor of outcome after living donor liver transplantation for patients with hepatocellular carcinoma beyond the Japan criteria
por: Yonemura, Yusuke, et al.
Publicado: (2020)

Impact of JMJD6 on intrahepatic cholangiocarcinoma
por: Kosai-Fujimoto, Yukiko, et al.
Publicado: (2022)

Efficacy of recombinant thrombomodulin for DIC after deceased donor liver transplantation: a case report
por: Kimura, Koichi, et al.
Publicado: (2016)

Chronic hepatitis E virus infection after living donor liver transplantation via blood transfusion: a case report
por: Kurihara, Takeshi, et al.
Publicado: (2016)

Association between Sarcopenia and Omega-3 Polyunsaturated Fatty Acid in Patients with Hepatocellular Carcinoma
por: Itoh, Shinji, et al.
Publicado: (2022)

Elevation of Mac‐2 binding protein glycosylation isomer after hepatectomy is associated with post‐hepatectomy liver failure, total Pringle time, and renal dysfunction
por: Imai, Daisuke, et al.
Publicado: (2019)

Curative surgery for multiple hepatocellular carcinomas after lenvatinib plus transarterial chemoembolization: a case report
por: Shiraishi, Jin, et al.
Publicado: (2023)

Electrohydraulic lithotripsy and rendezvous nasal endoscopic cholangiography for common bile duct stone: A case report
por: Kimura, Koichi, et al.
Publicado: (2019)

DsRNA Sequencing for RNA Virus Surveillance Using Human Clinical Samples
por: Izumi, Takuma, et al.
Publicado: (2021)

Cystic Liver Infection after Living Donor Liver Transplantation: A Case Report
por: Kudou, Kensuke, et al.
Publicado: (2014)

A third dose of the BNT162b2 mRNA vaccine sufficiently improves the neutralizing activity against SARS-CoV-2 variants in liver transplant recipients
por: Tomiyama, Takahiro, et al.
Publicado: (2023)

Solitary fibrous tumor in the liver: case report and literature review
por: Yugawa, Kyohei, et al.
Publicado: (2019)

A Multi-Facility, Randomized, Comparative Study Examining the Efficacy of Biliary Reconstruction Under a Surgical Microscope in Living Donor Liver Transplantation
por: Soyama, Akihiko, et al.
Publicado: (2021)

Neither MICA Nor DEPDC5 Genetic Polymorphisms Correlate with Hepatocellular Carcinoma Recurrence following Hepatectomy
por: Motomura, Takashi, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_gfeqpeqg2p4s43oasb788nst1c